SIBO vs. IBS: The Overlap, Post-Infectious Autoimmunity & Rome IV

The Overlap Between the Conditions

Irritable bowel syndrome and small intestinal bacterial overgrowth are two distinct medical concepts that often describe the exact same physical problem in a patient. Medical research shows a deep connection between the two. When doctors discuss irritable bowel syndrome in the context of bacterial overgrowth, they are looking at how an overgrowth of bacteria causes the specific symptoms of the syndrome.

Irritable bowel syndrome is a term that describes a group of symptoms. It is a label for chronic stomach pain connected to changes in a person’s bowel habits¹. The label describes what the person feels. It does not explain what causes the feelings.

Small intestinal bacterial overgrowth is a physical state inside the digestive tract. The small intestine is the middle section of the digestive system. It is where the body absorbs nutrients. In a healthy person, this area contains very few bacteria³. When bacteria multiply and grow out of control in this space, they consume the food the person eats. They produce gases and release toxins. This is a measurable physical problem, as detailed in our guide to what is SIBO⁴.

The primary connection between the two conditions is cause and effect. The overgrowth of bacteria in the small intestine is a major cause of irritable bowel syndrome. Research studies show that between 4 percent and 78 percent of people who have irritable bowel syndrome also have small intestinal bacterial overgrowth³. A large meta-analysis looked at 25 studies involving 3,192 people with the syndrome and 3,320 healthy controls. The analysis showed that the prevalence of bacterial overgrowth in the syndrome group was 31 percent⁷. When researchers compared the patients only to healthy controls, the odds of a patient having bacterial overgrowth were nearly five times higher⁷.

When a person goes to a doctor with pain and diarrhea, the doctor matches those symptoms to the rules for irritable bowel syndrome. The patient receives the syndrome diagnosis. However, the physical reason the patient has those symptoms is often the large population of bacteria in their small intestine⁸.

How the Conditions Are Similar

The daily experience of living with either condition is almost exactly the same. The symptoms overlap completely. Both conditions cause severe bloating, abdominal pain, excess gas, and unpredictable trips to the bathroom³, matching standard SIBO symptoms.

A person with either condition will notice that their symptoms react to specific types of food. Foods that are high in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) cause immediate problems. Onions, garlic, beans, and grains are common triggers⁸, which explains why many patients experience temporary relief using a low-FODMAP elimination diet. In both conditions, the person might wake up with a flat stomach. As they eat throughout the day, their abdomen becomes visibly swollen.

Both conditions involve problems with the speed of digestion. Some people have food that moves too fast, which causes urgent diarrhea. Other people have food that moves too slow, which causes constipation. Many people alternate between these two extremes⁸. Because the symptoms match, people often manage the symptoms of irritable bowel syndrome for years without realizing that bacteria are causing the disruption.

How the Conditions Are Different

While the symptoms feel the same, the medical definitions are completely different. Irritable bowel syndrome is defined by a set of symptom rules called the Rome IV criteria. According to these rules, a person has the syndrome if they experience abdominal pain at least one day a week for the last three months, and that pain is connected to changes in how often they have a bowel movement or changes in the form of their stool¹. There is no scan or physical measurement that proves a person has irritable bowel syndrome. A doctor makes the diagnosis by listening to the patient’s complaints and making sure they do not have other diseases like colon cancer⁹.

Small intestinal bacterial overgrowth is defined by physical measurements. Doctors confirm the condition by passing a tube into the small intestine, removing a sample of fluid, and counting the number of bacteria. If the count is higher than 1,000 colony-forming units per milliliter, the overgrowth is present⁷. Doctors can also measure the gases the bacteria produce. When bacteria eat sugars, they release hydrogen and methane gases. These gases enter the bloodstream, travel to the lungs, and leave the body in the breath. Doctors can measure these gases in a hydrogen and methane breath test to confirm the activity of the bacteria⁸.

The main difference is simple. Irritable bowel syndrome is a category of symptoms. Small intestinal bacterial overgrowth is the physical mechanism that creates those symptoms.

Feature	Irritable Bowel Syndrome	Small Intestinal Bacterial Overgrowth
Medical Concept	A symptom-based functional disorder⁹	A measurable physical condition⁸
Diagnostic Method	Symptom matching using Rome IV criteria²	Breath testing or intestinal fluid culture⁷
Location Focus	General changes in overall bowel habits	Specific bacterial populations in the small intestine⁴
Pathology	Often described as a brain-gut communication issue	Bacteria fermenting food and producing gas⁴
Food Reactions	Symptoms worsen with high-fiber foods and sugars⁸	Symptoms worsen with high-fiber foods and sugars⁸

The Post-Infectious Connection

The biological connection between these conditions becomes clear when tracing how the digestive system breaks down. Research shows a specific chain of events that leads a person to develop bacterial overgrowth, representing one of the best-documented root causes of SIBO. This overgrowth then creates the symptoms that receive the irritable bowel syndrome label. This chain of events usually starts with an episode of food poisoning¹⁴.

Food poisoning is the most common known cause of bacterial overgrowth. When irritable bowel syndrome starts this way, it is called post-infectious irritable bowel syndrome¹⁵. A person eats food contaminated with bacteria like Salmonella, Campylobacter, or Escherichia coli¹⁴. They experience vomiting and diarrhea for a few days. The infection clears, and the person feels better. However, a silent immune process continues in the background.

The bacteria that cause food poisoning release a specific toxin into the digestive tract. This toxin is called cytolethal distending toxin B¹⁴. The human immune system identifies this toxin as a threat. The immune system creates specific antibodies to find the toxin and neutralize it.

The problem relates to molecular mimicry. The bacterial toxin looks very similar to a natural protein inside the human body. This human protein is called vinculin. Vinculin is located inside special nerve cells in the wall of the small intestine. These cells are called the interstitial cells of Cajal. They act as the pacemakers for the entire digestive system¹⁴.

Because the bacterial toxin and the human vinculin protein look so much alike, the immune system makes a mistake. After the immune system neutralizes the bacterial toxin, the antibodies start attacking the vinculin protein in the person’s own nerve cells¹⁴. The immune system damages the pacemaker cells of the gut¹⁵. Dr. Mark Pimentel and his research team at Cedars-Sinai identified this specific autoimmune reaction. They developed blood tests to measure the anti-cytolethal distending toxin B antibodies and the anti-vinculin antibodies, providing physical proof of how an infection leads to the syndrome¹⁴.

The Failure of the Cleaning Wave

To understand how damaged nerve cells lead to the symptoms of irritable bowel syndrome, it is necessary to look at how the small intestine moves. The small intestine is a muscular organ. It contracts to push food and waste forward. Between meals, the pacemaker cells trigger a special sweeping motion. This motion is called the migrating motor complex (MMC)¹⁴.

The migrating motor complex is a strong, cleansing wave of muscle contractions. It sweeps through the small intestine every 90 to 120 minutes while a person is fasting. Its job is to clear out leftover food debris, dead cells, and stray bacteria. It pushes this waste down into the large intestine.

When the immune system damages the pacemaker cells after food poisoning, the migrating motor complex stops working properly. The cleansing waves become weak, or they stop happening entirely¹⁴. The small intestine loses its ability to clean itself. Without the sweeping motion, bacteria begin to settle in the small intestine. They stick to the walls and multiply.

This is the moment the small intestinal bacterial overgrowth begins. The bacteria build colonies in a place they do not belong¹⁴.

Months after the original food poisoning event, the bacteria reach high numbers. Whenever the person eats a meal, the food travels down into the small intestine. The overgrown bacteria consume the carbohydrates in the food. As the bacteria digest the food, they produce large amounts of gas. This gas causes immediate bloating, pain, and changes in bowel habits. The person visits a doctor, describes their pain and bathroom habits, and the doctor diagnoses them with irritable bowel syndrome⁹. The diagnosis is based on the symptoms, but the physical root cause is the damaged cleaning wave and the resulting bacteria.

Gas Types and Irritable Bowel Syndrome Subtypes

Irritable bowel syndrome affects people in different ways. Some people have constant diarrhea. Others have severe constipation. Doctors separate irritable bowel syndrome into different subtypes based on these bowel habits. The connection to bacterial overgrowth explains why these different subtypes exist. The specific symptoms a person experiences depend entirely on the specific type of gas the organisms in their gut produce.

Hydrogen Gas and Diarrhea

When the small intestine fills with common bacteria, those bacteria consume dietary sugars and ferment them. The waste product of this fermentation is hydrogen gas⁸. When bacteria produce a large amount of hydrogen gas in the small intestine, it causes a specific set of physical reactions.

The presence of the bacteria and their byproducts draws water into the intestines. The extra water makes the stool loose and watery. The gases also irritate the lining of the gut. This irritation causes the muscles to contract rapidly. The rapid movement pushes waste through the system too quickly⁸. The result is urgent, loose bowel movements.

When a person has a hydrogen-producing bacterial overgrowth, they experience frequent diarrhea, sudden urgency, and severe bloating. In the symptom-based diagnostic system, this presentation is labeled as diarrhea-predominant irritable bowel syndrome, or IBS-D⁸. The hydrogen gas acts as the physical driver of the diarrheal symptoms.

Methane Gas and Constipation

Not all overgrowths involve standard bacteria. Sometimes, a different type of single-celled organism takes over the small intestine. These organisms are called archaea. The most common archaea found in the human gut is called Methanobrevibacter smithii¹⁸.

These organisms survive by eating the hydrogen gas produced by other bacteria. When they consume the hydrogen, they produce methane gas as a waste product¹⁸. A methane overgrowth creates a completely different set of symptoms than a hydrogen overgrowth.

Methane gas acts as a paralytic agent on the muscles of the digestive tract. When methane gas touches the nerves in the intestinal wall, it slows down the muscle contractions⁹. The transit time of the gut slows down significantly. Because the waste moves so slowly, the large intestine absorbs too much water from the stool. This makes the stool hard and dry.

This condition is officially recognized as intestinal methanogen overgrowth¹⁸. When a person has a large amount of methane gas slowing down their digestion, they experience severe constipation, hard stools, and heavy bloating. Doctors using the Rome IV criteria look at this pattern and diagnose the person with constipation-predominant irritable bowel syndrome, or IBS-C⁸. The methane gas provides a measurable explanation for why the bowel refuses to move.

The relationship between methane and constipation creates a compounding cycle. The methane slows down the gut. Because the gut is moving slowly, the cleaning wave fails to push waste away. This allows more organisms to grow, which produces more methane⁹. This physical process explains why constipation in these patients is difficult to resolve with standard fiber supplements.

Hydrogen Sulfide Gas and Severe Irritation

Research identifies a third type of gas involved in these digestive conditions. Certain types of bacteria, such as Desulfovibrio, consume sulfur from the diet. They produce hydrogen sulfide gas²².

Hydrogen sulfide is highly toxic to the cells lining the gut. When bacteria produce this gas in the small intestine, it causes intense irritation and inflammation. The body attempts to flush the irritating gas and bacteria out of the system rapidly. This results in severe, explosive diarrhea²². The gas also produces a distinct, foul odor resembling rotten eggs.

People with a hydrogen sulfide overgrowth experience extreme symptoms. They have severe abdominal pain, sudden urgency, and a feeling of sickness after eating. Because hydrogen sulfide is difficult to measure on standard breath tests, these patients often receive negative test results for standard overgrowth. They are then diagnosed with severe diarrhea-predominant irritable bowel syndrome⁸. A specific gas-producing bacteria irritates their intestinal lining, but they receive a functional bowel disorder label.

Visceral Hypersensitivity and Physical Expansion

One of the defining features of irritable bowel syndrome is pain. According to the diagnostic rules, a person must experience abdominal pain to receive the diagnosis¹. The medical term for this pain is visceral hypersensitivity.

Visceral hypersensitivity means that the nerves inside the organs of the digestive tract are overly sensitive²⁴. In a healthy person, the normal digestion of food, the passage of a small amount of gas, and the contraction of the bowel muscles happen without the brain noticing. The brain filters out the signals. In a person with visceral hypersensitivity, the nerves in the gut have a low threshold for pain²⁴. Normal movements and normal amounts of gas trigger the nerves to send strong pain signals to the brain. The person feels intense discomfort from basic digestive processes²⁶.

The connection between bacterial overgrowth and visceral hypersensitivity is a matter of volume and pressure. When a person has an overgrowth of bacteria, the bacteria ferment food and create massive amounts of hydrogen or methane gas⁹. The small intestine is a narrow tube. It is not built to hold large pockets of gas.

When the bacteria release gas, the gas rapidly expands the walls of the small intestine. This physical stretching of the intestinal wall activates mechanical stretch receptors in the nerves²⁴. Because the person has overly sensitive nerves, the stretching causes severe pain. The overgrowth of bacteria provides the physical pressure. The sensitive nerves translate that pressure into the severe cramping associated with irritable bowel syndrome.

The pain is often worse shortly after a meal. The bacteria live high up in the small intestine. When the person eats, the food reaches the bacteria within thirty to ninety minutes⁸. The bacteria immediately begin fermenting the food and producing gas. This expands the sensitive small intestine. This rapid onset of pain and bloating after eating is a primary feature of both the physical bacterial overgrowth and the clinical syndrome⁸.

Low-Grade Inflammation and Mast Cells

For decades, the medical community considered irritable bowel syndrome a disorder of the mind. Doctors believed that stress and anxiety caused the bowel symptoms. They noted that the intestinal tissues looked normal under a microscope. There was no obvious damage or ulceration, unlike in Crohn’s disease or ulcerative colitis.

Modern research into the bacterial connection changed this view. When bacteria grow in the small intestine, they interact with the human immune system. The walls of the bacteria shed particles that irritate the lining of the gut. This constant irritation causes a low-grade inflammation²⁹.

This low-grade inflammation is subtle. It does not destroy the tissue, which explains why older medical tests missed it. However, it is strong enough to activate specific immune cells called mast cells³⁰. Mast cells live in the lining of the gut. When they detect the irritating bacteria, they break open and release strong chemicals into the surrounding tissue.

One of the main chemicals released by mast cells is serotonin³⁰. While serotonin is often associated with the brain, the vast majority of the body’s serotonin is located in the gut. In the digestive tract, serotonin controls muscle movement and nerve signaling³¹.

When the bacteria trigger the mast cells, the mast cells release a flood of serotonin into the gut lining³⁰. This massive dose of serotonin causes the muscles of the intestine to spasm and contract violently. These spasms are the physical cause of the cramping and diarrhea seen in irritable bowel syndrome³².

This immune response directly links the presence of bacteria in the small intestine to the symptoms of the syndrome. The bacteria trigger the mast cells. The mast cells release serotonin. The serotonin causes the bowel to spasm. The spasms cause the pain and diarrhea. The doctor observes the pain and diarrhea and diagnoses the patient with irritable bowel syndrome. The entire process connects back to the subtle inflammation caused by the misplaced bacteria³⁰.

The Microbiome Shift

The medical understanding of these conditions continues to change. In the past, doctors thought small intestinal bacterial overgrowth was a rare condition. They believed it only happened to people who had major abdominal surgeries or anatomical defects in their intestines¹². They assumed the bacteria in the overgrowth were just normal colon bacteria that had accidentally backed up into the small intestine¹².

Advanced technology proves this old view incorrect. Researchers now use high-throughput DNA sequencing to study the exact types of bacteria living in the small intestines of people with irritable bowel syndrome³⁴. They have discovered that the overgrowth is not random colon bacteria. The overgrowth is caused by specific, opportunistic strains of bacteria.

The two most common bacteria found in these overgrowths are Escherichia coli and Klebsiella³⁵. These specific strains are highly effective at fermenting carbohydrates and surviving in the unique environment of the small intestine. When researchers sequence the fluid from the small intestines of people with severe irritable bowel syndrome, they find massive populations of Escherichia coli and Klebsiella⁷. A study using shotgun sequencing showed that two main strains of Escherichia coli and two species of Klebsiella represented 40.2 percent of all the bacteria in the small intestine of these patients⁴. The presence of these specific bacteria correlates directly with the severity of the person’s abdominal pain, diarrhea, and bloating³⁷.

This precise genetic data forces the medical community to recognize the connection. Irritable bowel syndrome is shifting from an unexplained functional disorder to a microbiome-based disease¹².

Updated Clinical Guidelines

The recognition of this connection is not limited to research laboratories. It is entering mainstream medical practice. The American College of Gastroenterology publishes the official guidelines that doctors use to treat digestive diseases. The authors of the 2020 guidelines include experts from the Mayo Clinic, Cedars-Sinai, Northwestern University, the University of Michigan, the Icahn School of Medicine at Mount Sinai, and the University of North Carolina at Chapel Hill³⁸.

In their updated clinical guidelines for the management of irritable bowel syndrome, the American College of Gastroenterology officially acknowledges the role of bacterial overgrowth. The guidelines suggest that doctors use breath testing to look for bacterial overgrowth in patients who have the symptoms of irritable bowel syndrome¹³.

By advising doctors to test for bacterial overgrowth in these patients, the major medical organizations confirm that the symptoms of the syndrome are driven by the physical presence of the bacteria³⁹. The guidelines also endorse the use of gut-selective antibiotics—such as targeted prescription antibiotics like Rifaximin—to treat the symptoms of diarrhea-predominant irritable bowel syndrome³⁹. These antibiotics stay in the gut and kill the overgrown bacteria in the small intestine. When the bacteria die, the symptoms of the syndrome improve. This treatment provides further proof that the bacteria cause the syndrome.

The Diagnostic Dilemma

Despite the clear biological connection between the two conditions, patients face a confusing diagnostic process. Because irritable bowel syndrome is a diagnosis of exclusion, a patient undergoes many tests before receiving the label. They might have blood tests to check for celiac disease, stool tests to check for inflammatory markers, and a colonoscopy to check for structural diseases¹¹.

When all these tests come back normal, the doctor applies the Rome IV criteria. Since the patient has abdominal pain and changes in their bowel habits, they meet the criteria. They are told they have irritable bowel syndrome².

The problem is that a standard medical workup does not automatically include a breath test or a fluid culture for small intestinal bacterial overgrowth⁹. A person can go through the entire diagnostic process, receive their syndrome label, and never know that bacteria are growing in their small intestine. The Rome IV criteria do not require doctors to rule out bacterial overgrowth before diagnosing the syndrome⁹.

This creates a situation where millions of people hold an irritable bowel syndrome diagnosis, while the actual driver of their symptoms remains untested. They are told to eat more fiber or take anti-spasm medications⁸. Because fiber feeds the overgrown bacteria, the patient’s symptoms often get worse. The bacteria ferment the extra fiber, produce more gas, stretch the sensitive nerves, and trigger the mast cells to release serotonin. The patient believes their syndrome is incurable, when they are actually feeding a bacterial overgrowth⁸.

The availability of specialized blood tests provides a solution to this dilemma. Doctors can test a patient’s blood for the anti-cytolethal distending toxin B and anti-vinculin antibodies through the IBS-Smart blood test⁵. If a patient has a high level of these antibodies, it proves that their immune system attacked their gut nerves after an episode of food poisoning¹⁶. This blood test allows doctors to see the exact mechanism that ruined the patient’s migrating motor complex. It proves that the patient’s irritable bowel syndrome is an autoimmune condition that led to a bacterial overgrowth⁵.

The connection between irritable bowel syndrome and small intestinal bacterial overgrowth represents a fundamental shift in digestive medicine. The conditions share the exact same clinical presentation, including chronic abdominal pain, severe bloating, and disrupted bowel habits. For a significant percentage of patients, the two conditions are linked by a clear biological chain of events. A gastrointestinal infection triggers an autoimmune response, which damages the nerves of the small intestine. This damage stops the natural cleansing waves of the gut, allowing specific bacteria and archaea to accumulate. These organisms ferment dietary carbohydrates, producing large volumes of hydrogen, methane, and hydrogen sulfide gases. The gases expand the intestine, trigger pain in highly sensitive nerves, and provoke low-grade immune inflammation. While the medical system uses the Rome IV criteria to label the resulting symptoms as irritable bowel syndrome, advanced sequencing, breath testing, and antibody markers confirm that the physical presence of bacterial overgrowth is driving the dysfunction. Understanding this connection changes the focus from managing a vague collection of symptoms to addressing the specific microbial and physical disruptions inside the digestive tract.

Works Cited & Scientific References 40

▼